147 related articles for article (PubMed ID: 7605579)
1. Dissemination and tissue invasiveness in murine acute leukemia associated with acquisition of p53 mutation and loss of wild-type p53.
Hsiao M; Wu CY; Low J; Pattengale P; Yeargin J; Haas M
Mol Carcinog; 1995 Jun; 13(2):112-21. PubMed ID: 7605579
[TBL] [Abstract][Full Text] [Related]
2. P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines.
Yeargin J; Cheng J; Yu AL; Gjerset R; Bogart M; Haas M
J Clin Invest; 1993 May; 91(5):2111-7. PubMed ID: 8486778
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y
Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127
[TBL] [Abstract][Full Text] [Related]
4. Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.
Hsiao M; Low J; Dorn E; Ku D; Pattengale P; Yeargin J; Haas M
Am J Pathol; 1994 Sep; 145(3):702-14. PubMed ID: 8080050
[TBL] [Abstract][Full Text] [Related]
5. Mutation, loss of heterozygosity, and recombination of the p53 gene in mouse forestomach tumors induced by 2-amino-3,4-dimethylimidazo[4,5-f]quinoline.
Ushijima T; Makino H; Okonogi H; Hosoya Y; Sugimura T; Nagao M
Mol Carcinog; 1995 Jan; 12(1):23-30. PubMed ID: 7818762
[TBL] [Abstract][Full Text] [Related]
6. Clonal expansion of p53 mutant cells in leukemia progression in vitro.
Wada H; Asada M; Nakazawa S; Itoh H; Kobayashi Y; Inoue T; Fukumuro K; Chan LC; Sugita K; Hanada R
Leukemia; 1994 Jan; 8(1):53-9. PubMed ID: 8289498
[TBL] [Abstract][Full Text] [Related]
7. Nonhereditary p53 mutations in T-cell acute lymphoblastic leukemia are associated with the relapse phase.
Hsiao MH; Yu AL; Yeargin J; Ku D; Haas M
Blood; 1994 May; 83(10):2922-30. PubMed ID: 8180387
[TBL] [Abstract][Full Text] [Related]
8. p53 gene mutations with chromosome 17 abnormalities in chronic myelogenous leukemia blast crisis patients persist in long-term cell lines but may be acquired in acute myeloid leukemia cells in vitro.
Sen S; Zhou H; Andersson BS; Cork A; Freireich EJ; Stass SA
Cancer Genet Cytogenet; 1995 Jul; 82(1):35-40. PubMed ID: 7627932
[TBL] [Abstract][Full Text] [Related]
9. Infrequent mutations in the P53 gene in primary human T-cell acute lymphoblastic leukemia.
Jonveaux P; Berger R
Leukemia; 1991 Oct; 5(10):839-40. PubMed ID: 1961018
[TBL] [Abstract][Full Text] [Related]
10. Allelic loss on chromosome 4 (Lyr2/TLSR5) is associated with myeloid, B-lympho-myeloid, and lymphoid (B and T) mouse radiation-induced leukemias.
Cleary H; Boulton E; Plumb M
Blood; 2001 Sep; 98(5):1549-54. PubMed ID: 11520806
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
12. Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia.
Kawamura M; Kikuchi A; Kobayashi S; Hanada R; Yamamoto K; Horibe K; Shikano T; Ueda K; Hayashi K; Sekiya T
Blood; 1995 May; 85(9):2546-52. PubMed ID: 7727782
[TBL] [Abstract][Full Text] [Related]
13. The p53 gene in pediatric therapy-related leukemia and myelodysplasia.
Felix CA; Hosler MR; Provisor D; Salhany K; Sexsmith EA; Slater DJ; Cheung NK; Winick NJ; Strauss EA; Heyn R; Lange BJ; Malkin D
Blood; 1996 May; 87(10):4376-81. PubMed ID: 8639798
[TBL] [Abstract][Full Text] [Related]
14. p53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines.
Servomaa K; Kiuru A; Grénman R; Pekkola-Heino K; Pulkkinen JO; Rytömaa T
Cell Prolif; 1996 May; 29(5):219-30. PubMed ID: 8782485
[TBL] [Abstract][Full Text] [Related]
15. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.
Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW
J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408
[TBL] [Abstract][Full Text] [Related]
16. Identification of p53 mutations in archival prostate tumors. Sensitivity of an optimized single-strand conformational polymorphism (SSCP) assay.
Shi XB; Bodner SM; deVere White RW; Gumerlock PH
Diagn Mol Pathol; 1996 Dec; 5(4):271-8. PubMed ID: 8955619
[TBL] [Abstract][Full Text] [Related]
17. Frequent mutations in the p53 gene in human myeloid leukemia cell lines.
Sugimoto K; Toyoshima H; Sakai R; Miyagawa K; Hagiwara K; Ishikawa F; Takaku F; Yazaki Y; Hirai H
Blood; 1992 May; 79(9):2378-83. PubMed ID: 1571549
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of p53 alteration in acute leukemias.
Schottelius A; Brennscheidt U; Ludwig WD; Mertelsmann RH; Herrmann F; Lübbert M
Leukemia; 1994 Oct; 8(10):1673-81. PubMed ID: 7523798
[TBL] [Abstract][Full Text] [Related]
19. p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia.
Nakai H; Misawa S; Tanaka S; Nishigaki H; Taniwaki M; Yokota S; Horiike S; Takashima T; Seriu T; Nakagawa H
Leukemia; 1993 Oct; 7(10):1547-51. PubMed ID: 8412316
[TBL] [Abstract][Full Text] [Related]
20. Role of the p53 tumor suppressor gene in the pathogenesis and in the suppression of acute lymphoblastic T-cell leukemia.
Yeargin J; Cheng J; Haas M
Leukemia; 1992; 6 Suppl 3():85S-91S. PubMed ID: 1602834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
